Concepedia

Effect of intravitreal ranibizumab on the ocular circulation of the untreated fellow eye

Masahiko Sugimoto, Takayasu Nunome, Rie Sakamoto, Maki Kobayashi, Mineo Kondo

Graefe s Archive for Clinical and Experimental Ophthalmology · 2017 · 16 citations · 38 references

DOIFull text

Open access

Abstract

These findings indicate that if ranibizumab enters the systemic circulation, the concentration is not high enough to affect the ocular circulation of the fellow eyes.

References

38

Ranibizumab for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine · 2006 · 5.8K citations · Full text

Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

David M. Brown, Peter K. Kaiser, Mark Michels et al. · New England Journal of Medicine · 2006 · 3.5K citations

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

New England Journal of Medicine · 2011 · 2.6K citations · Full text

Ranibizumab for Diabetic Macular Edema

Quan Dong Nguyen, David M. Brown, Dennis M. Marcus et al. · Ophthalmology · 2012 · 1.6K citations

, , +4

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

New England Journal of Medicine · 2015 · 1.5K citations · Full text